Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-13

FDA Approved: ALOCRIL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ALOCRIL (nedocromil sodium) by Allergan, Inc. The action approves changes described in the supplement for this produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALOCRIL (NEDOCROMIL SODIUM)

Snippet

SUPPL AP for ALOCRIL (NEDOCROMIL SODIUM)